Patient-derived lymphoma spheroids reveal predictive markers of glofitamab resistance in relapsed/refractory B-NHL

Journal:
Blood
Published:
Affiliations:
24
Authors:
25
Institutions Authors Share
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), France
2.850000
0.11
Centre de Recherche en Cancérologie de Toulouse (CRCT), France
2.050000
0.08
LabEx Toulouse Cancer (LabEx TOUCAN), France
2.050000
0.08
Institut Carnot CALYM, France
2.050000
0.08
Molecular Medicine Partnership Unit (MMPU), Germany
1.100000
0.04
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain
1.000000
0.04
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain
1.000000
0.04
F. Hoffmann-La Roche Ltd., Switzerland
1.000000
0.04
Roche, Switzerland
1.000000
0.04
LabEx Immuno Graft Oncology (IGO), France
1.000000
0.04
Rennes University Hospital (CHU Rennes), France
1.000000
0.04
Lyon University Hospital (HCL), France
1.000000
0.04
Institute of Human Genetics (IGH), France
1.000000
0.04
Dijon University Hospital, France
1.000000
0.04
Alps Grenoble University Hospital (CHU Grenoble Alpes), France
1.000000
0.04
Centre Hospitalier Universitaire de Lille (CHU Lille), France
1.000000
0.04
Montpellier University Hospital, UM, France
1.000000
0.04
University Hospital Duesseldorf (UKD), Germany
0.600000
0.02
Center for Integrated Oncology Aachen Bonn Köln Düsseldorf (CIO), Germany
0.600000
0.02
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany
0.600000
0.02
Heinrich Heine University Düsseldorf (HHU), Germany
0.600000
0.02
EMBL - Heidelberg, Germany
0.500000
0.02